Project Grant R61HL173904
Award Date
5/15/25
Completion Date
3/31/26
Dollars Obligated
$323K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded Sigt LLC a $293,880 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program. The purpose of this Phase 1 SBIR grant is to develop a novel "Intraoperative Cardiac Pulsed Field Ablation Lesion Assessment System" (PFA-LAS) that can monitor procedure parameters and confirm durable lesion formation during cardiac pulsed electric field ablation procedures for atrial...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $293,653 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to 3DT Holdings, LLC, a minority-owned biomedical engineering company. The funding will support the development of a software tool to optimize cardiac resynchronization therapy (CRT), conduction system pacing (CSP), and left ventricular endocardial pacing (LVEP) for heart failure patients with left bundle branch block and ischemia. The project...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $343,203 to Cyion Technologies LLC to develop a novel in vitro electrophysiology system for high-throughput measurement of intracellular action potential (IAP) in human-derived cardiomyocytes. The system leverages a 3D nanoelectrode array (NEA) technology to enable scalable recordings of IAP signals from many individual cardiomyocytes. This...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $437,461 to 3DT Holdings, LLC, a minority-owned biomedical engineering company, to develop a novel stabilization catheter for His pacing lead implants. The goal is to improve the success rate and accuracy of His bundle pacing, an emerging alternative to cardiac resynchronization therapy (CRT) for heart failure patients. The project aims...
This $580,863 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of silicon nanowire-engineered human cardiac organoids for heart repair. The key products or services to be delivered include: Optimizing the surface roughness of electrically conductive silicon nanowires (e-SiNWs) to improve their electrical interactions with human pluripotent stem cell-derived cardiomyocytes...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
This $2,139,180 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to develop advanced MRI methods for simultaneously and efficiently evaluating both the cardiac and respiratory systems in pediatric cardiopulmonary diseases. The key products and services to be delivered under this grant include: Developing a "free-running" approach to cardiopulmonary imaging that can provide comprehensive anatomical and...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), awarded a $251,156 project grant to City Labs, Inc., a minority-owned small business in Miami, Florida, to develop a betavoltaic power source for leadless cardiac pacemakers. The project aims to design and manufacture a compact, long-lasting power solution that can be integrated into the titanium housing of leadless pacemakers, enabling further miniaturization...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is supporting the development of a novel magnetic rotational atherectomy platform to address coronary lesions. The $413,595 award to Unandup, LLC will fund the refinement of a prototype over-the-wire atherectomy device that uses magnetic fields instead of high-speed driveshafts to safely and effectively debulk severely calcified coronary...
This $488,026 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the development of a flexible bioelectronic microarchitecture that integrates a capillary-like media delivery network and tissue-like sensing network to improve cardiac tissue engineering. The University of Massachusetts is the prime recipient, with a sub-award to Harvard University to collaborate on the project. The key products and services to...